Hyphens Pharma Bags Rights To Stelara Rival

DKSH’s Favorex Licenses Alvotech’s Ustekinumab In Singapore, Malaysia And Philippines

 
• By David Wallace
South-east Asia From Space Globe Planet Earth
Hyphens Pharma has secured rights to ustekinumab in south-east Asia • Source: Alamy

More from Deals

More from Business